Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-195-2 | CAS number: 7446-09-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- other: not rated
- Rationale for reliability incl. deficiencies:
- other: Well and detailed documented study.
Data source
Reference
- Reference Type:
- publication
- Title:
- The Roles of pH and Ionic Species in Sulfur Dioxide- and Sulfite-Induced Bronchoconstriction.
- Author:
- Fine, J.M. et al.
- Year:
- 1 987
- Bibliographic source:
- Am. Rev. Respir. Dis. 136: 1122-1126
Materials and methods
- Type of sensitisation studied:
- respiratory
- Study type:
- study with volunteers
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A study was performed to access the relative brochoconstriction potency of the different chemical forms of sulfite at various pH values. 10 asthmatic subjects inhaled sodium sulfite aerosols through a mouthpiece in 6 concentrations (0.03, 0.1, 0.3, 1.0, 3.0 and 10.0 mg/ml) at 3 levels of pH (pH 4.0, 6.6 and 9.0) for 1 min in 10 min intervals. The different pH levels were tested on 3 subsequent days. Concentration-response curves of specific airway resistance before and after inhalations were performed. Furthermore, the role of acidity was determined by buffered acetic acid aerosols.
- GLP compliance:
- no
Test material
- Reference substance name:
- Sodium sulphite
- EC Number:
- 231-821-4
- EC Name:
- Sodium sulphite
- Cas Number:
- 7757-83-7
- Molecular formula:
- NA2SO3
- IUPAC Name:
- disodium sulfite
- Details on test material:
- - Name of test material (as cited in study report): sodium sulfite
Constituent 1
Method
- Type of population:
- other: general, only asthmatics
- Ethical approval:
- confirmed, but no further information available
- Subjects:
- - Number of subjects exposed: 10 nonsmoking volunteers
- Sex: males and females
- Age: 22 – 34 years old
- Race: North American
- Other: - Clinical history:
- - all subjects had asthma, as defined by a history of recurrent episodes of wheezing, chest tightness, and reversible airway obstructions
- no subject took theophylline or sympathomimetric drugs within 12 h or consumed caffeine within 4 h before any experiment.
- no subject gave a history suggestive of sensitivity to ingest sulfite preservative - Controls:
- no data
- Route of administration:
- inhalation
- Details on study design:
- - first, the effects of inhaled sodium sulfite were compared delivered at 3 different levels of pH: pH 9 was chosen to study the effects of sulfite ion (SO32-) in the absence of significant amounts of SO2 or bisulfite (HSO3-); pH 6.6 was chosen to study the effects of bisulfite – in addition pH 6.6 is the recorded pH of human airways; pH 4, since SO2 generation increases by more than 2 orders of magnitude compared to pH 6.6.
- To test the role of change in airway pH as would be induced by release of hydrogen ions by dissolved SO2 and sulfites, the bronchoconstriction effects of buffered acetic acid aerosol matched with sulfite pH 4 were also studied.
- each subject was tested on 7 separate days; concentration response curves were performed to methacholine on the first day and to inhaled sodium sulfite aerosol at the three different pHs on 3 subsequent days- the buffered acetic acid aerosol was tested on another day
- the challenges were performed in single-blind fashion
- to exclude “specific sulfite sensitivity” an oral metabisulfite challenge was also performed on each subject – sensitivity to SO2 was also tested
- the subjects inhaled increasing concentrations of aerosolized Na2SO3 at each pH during 1 min of tidal breathing
- bronchoconstrictor response was assessed by measuring specific airway resistance (SRaw) before and after each challenge
A detailed method description is provided in the original paper.
Results and discussion
- Results of examinations:
- -9/10 subjects developed significant bronchoconstriction (SRaw > 100 % above baseline) after sulfite inhalation at all 3 levels of pH during increasing concentrations; a 100 % increase in SRaw occurred at the lowest sulfite concentration at pH 4 and at the highest concentration at pH 9
- the mean values for PC100 (100 % increase in Sraw) were 0.17 mg/mL at pH 4, 0.49 mg/mL at pH 6.6 and 2.10 mg/mL at pH 9.0 and were significantly different. The bronchoconstriction effects were clearly pH-dependent.
- The one who did not develop bronchoconstriction at any pH was also the only one who did not develop bronchoconstriction after inhaling as much as 8 ppm SO2
Applicant's summary and conclusion
- Conclusions:
- The results of this study confirm that inhaled sulfite aerosols are a stimulus to bronchoconstriction in subjects with asthma. The bronchoconstrictor effects of sodium sulfite aerosols were clearly pH-dependent, with the greatest effect occurring at the most acid pH (pH 4). However the acidity itself seems not to be the stimulus in this study. Between the two ionic forms of sulfite the results suggest that bisulfite is either the more potent or the only bronchoconstrictor stimulus.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.